FNDA offers diversified small-cap exposure, attractive valuation versus indices, and lags VUG’s tech-heavy performance. Learn ...
Predication markets lets users turn political opinions into tradeable instruments, but ethics concerns and insider trading ...
Wall Street forecasters expect the stock market to grind higher in 2026 as earnings grow, the Fed cuts rates, and the US ...
The S&P 500 is forecasted to reach 7,500 by mid-2026 and potentially 8,000 by year-end, driven by AI, Fed easing, and ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Zacks Investment Research on MSN
Why is CRISPR Therapeutics (CRSP) up 3.3% since last earnings report?
It has been about a month since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 3.3% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Oscars Best Original Score Commentary (Updated Dec. 7, 2025): An unusually diverse field of composers and contenders spans experimental soundscapes, franchise blockbusters and intimate character ...
Kalshi and Crypto.com want the Commodity Futures Trading Commission, rather than the states, to regulate their businesses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback